Trial PaperAdolescentsDepressive DisordersAnxiety DisordersChronic PainPalliative & End-of-Life DistressLSD

Attenuation and anticipation: A therapeutic use of lysergic acid diethylamide

This open-label clinical study (n=128) investigated whether LSD (100μg) can alleviate death-anxiety in terminally ill patients by decreasing the anticipation of their illness, and found that the administration of LSD was universally well tolerated. Specific effects included a general lift of mood that lasted for 11-12 hours, acute pain relief that lasted 12 hours, decreased the total pain intensity for 3 weeks, and diminished concern over the anticipation of death for up to 3 days after administration.

Authors

  • Kast, E.

Published

Psychiatric Quarterly
individual Study

Abstract

Introduction

Theoretical reasons for the use of LSD as an analgesic agent are elaborated. Two characteristics of the LSD experience which are of possible therapeutic use in situations where anticipation is of less use than in ordinary life: (1) the loss of the ability to anticipate, through the lessening of the power of words, and (2) the expansion of the immediate sensory life.

Method

Only one-dose administrations of LSD were undertaken in this study of 128 patients. All were informed of their diagnosis and were pre-terminal, meaning that death could be foreseen withinone to two months. The following observations were conducted: (1) Pain intensity, (2) Affective changes, (3) Approach to illness and death, (4) Sleep patterns, (5) Visual disturbances and hallucinations, (6) Fear and panic reaction.

Results

(1) A precipitous drop in pain occurred about 2-3 hours after LSD administration. This pain relief lasted 12 hours, but the total pain intensity was less for a protracted period (3 weeks). (2) There was a general lift of mood, almost euphoria, which lasted for about 11-12 hours, after which time the mood fell to its original level. (3) Under LSD, patients were so strikingly unconcerned about death ,or any other anticipatory concern that this seemed important. Rather often definite evidence of depression (like somatization or nagging attitudes by patients) associated with an air of unconcernedness was encountered. The patient was able to state that death was near, that the situation was hopeless, but felt that this did not matter. (4) The first night [of sleep] after LSD administration was almost invariably a good one. After that a meaningful reduction of disturbances up to .about 10 nights was noted, which is also the time when concern about the morbid condition returned. (5) At the height of the LSD reaction less than 10% of the patients 'had actual hallucinations, while about 55% (75 patients) confessed to visual distortions. (6) Seven patients had panic, while 42 suffered mild anxiety reactions. None of the reactions was of sufficiently severe character to terminate the LSD reaction. All were amenable to psychotherapy.

Discussion

In a series of 128 patients the analgesic action of LSD is further confirmed, and the undesirable pharmacologic effects are discussed. The relative safety of the drug for that use is demonstrated, and further study is recommended.

Available with Blossom Pro

Research Summary of 'Attenuation and anticipation: A therapeutic use of lysergic acid diethylamide'

Introduction

LSD is described as producing profound changes in both mental and autonomic functioning, and the paper frames its therapeutic potential specifically for patients in the painful terminal stages of serious illness. Earlier clinical observation and theorising led the investigators to focus on a psychological mechanism they call anticipation — the human capacity to simulate and plan for future events through symbolic thinking and language. The authors argue that anticipation, ordinarily adaptive, can magnify suffering in situations of inescapable doom such as terminal cancer, and that attenuating anticipatory processes could reduce emotional torment. The study sets out to explore whether a single administration of LSD can therapeutically reduce suffering in pre‑terminal patients by (1) diminishing anticipatory symbolic processing through an attenuation of the power of words and concepts and (2) expanding immediate sensory experience so that present sensations gain relative prominence over future‑oriented distress. The investigators also propose mechanistic bases for analgesia under LSD, including reduction of focused attention on pain, recruitment of minor sensations to compete with major pain signals, diminished cortical control of thought, and loosening of ego boundaries that may permit the patient to dissociate from the ailing body part.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

Related Clinical Trial

Cited By (10)

Papers in Blossom that reference this study

Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation

Reynolds, L. M, Stack, A., Akroyd, A., Sundram, F. et al. · International Journal of Environmental Research and Public Health (2021)

22 cited
Classic psychedelics as therapeutics for psychiatric disorders

Nichols, C. D., Hendricks, P. S. · Handbook of Behavioral Neuroscience (2020)

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

Schindler, E. A. D., Wallace, R. M., Sloshower, J. A. et al. · Frontiers in Pharmacology (2018)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.